Health Canada’s chief medical advisor Supriya Sharma discussed the experimental COVID-19 pill molnupiravir, which drugmaker Merck says reduces hospitalizations and deaths by half in people recently infected with the coronavirus. Sharma told reporters that Health Canada is working on the review process with international partners after receiving a submission from Merck in August.
Canada
Health Canada looking into experimental COVID-19 pill molnupiravir, Sharma says
More Videos
-
Carbon rebate payments for small businesses ahead of schedule: Freeland
-
Feds defend temporary GST cuts amid economists’ criticism
-
Business Matters: Canada Post strike enters 11th day
-
Canada on ‘clear path’ to reach NATO’s 2% target: Trudeau
-
Trudeau condemns violent anti-NATO protests in Montreal: ‘Never any room for antisemitism’
-
World Juniors sex assault case: Court to hear legal arguments of 5 hockey players
You are viewing an Accelerated Mobile Webpage.
View Original Article